The endocrine system is a complex network of glands and organs that produce and release hormones, chemical messengers that regulate various physiological processes and maintain homeostasis within the body. These hormones are secreted directly into the bloodstream and travel to target cells or organs, where they exert their effects by binding to specific receptors.

Key components of the endocrine system include glands such as the pituitary, thyroid, adrenal, pancreas, and gonads (testes and ovaries), as well as hormone-producing tissues like the hypothalamus and pineal gland. Each gland or organ produces distinct hormones with specific functions, regulating processes such as metabolism, growth and development, reproduction, stress response, and electrolyte balance.

The endocrine system works in coordination with the nervous system to regulate bodily functions and respond to internal and external stimuli. Imbalances or dysfunctions in the endocrine system can lead to various disorders, such as diabetes, thyroid disorders, adrenal insufficiency, and reproductive hormone imbalances. Proper functioning of the endocrine system is crucial for maintaining overall health and well-being

Major disorders of the endocrine system encompass a range of conditions affecting hormone production, secretion, and regulation. These include:

1. Diabetes Mellitus: A chronic metabolic disorder characterized by high blood sugar levels due to inadequate insulin production (Type 1 diabetes), insulin resistance, or impaired insulin function (Type 2 diabetes). Diabetes can lead to complications affecting the eyes, kidneys, nerves, heart, and blood vessels.
2. Thyroid Disorders: Including hypothyroidism (underactive thyroid), hyperthyroidism (overactive thyroid), and thyroid nodules. These conditions disrupt thyroid hormone production, leading to symptoms such as fatigue, weight changes, temperature sensitivity, and mood disturbances.
3. Adrenal Disorders: Such as Addison's disease (adrenal insufficiency) and Cushing's syndrome (excess cortisol). Addison's disease results from insufficient adrenal hormone production, causing fatigue, weight loss, low blood pressure, and electrolyte imbalances. Cushing's syndrome is characterized by excessive cortisol levels, leading to weight gain, high blood pressure, and metabolic disturbances.
4. Pituitary Disorders: Including pituitary adenomas (tumors), hypopituitarism (insufficient hormone production), and hyperpituitarism (excess hormone production). These disorders can disrupt hormone regulation, affecting growth, reproduction, and metabolism.
5. Reproductive Hormone Disorders: Such as polycystic ovary syndrome (PCOS), infertility, and disorders of sexual development (DSD). These conditions involve hormonal imbalances affecting reproductive function, menstrual cycles, and fertility.
6. Parathyroid Disorders: Including hyperparathyroidism (excess parathyroid hormone) and hypoparathyroidism (insufficient parathyroid hormone). These disorders disrupt calcium and phosphorus balance, leading to bone disorders, kidney stones, and neurological symptoms.
7. Growth Disorders: Such as gigantism (excess growth hormone in childhood) and acromegaly (excess growth hormone in adulthood), as well as short stature due to growth hormone deficiency or other causes.

These disorders can have significant impacts on health and quality of life, requiring medical management to control symptoms, prevent complications, and restore hormone balance.

1. Diabetes Mellitus: Insulin resistance is a hallmark of type 2 diabetes, where tissues become less responsive to insulin's actions, leading to hyperinsulinemia as the pancreas produces more insulin to compensate. Chronic hyperinsulinemia and insulin resistance can further impair glucose regulation, exacerbating blood sugar dysregulation and contributing to the progression of diabetes.
2. Thyroid Disorders: Insulin resistance and metabolic syndrome components such as obesity and dyslipidemia can disrupt thyroid hormone metabolism and function. Elevated insulin levels may inhibit the conversion of thyroxine (T4) to triiodothyronine (T3), leading to alterations in thyroid hormone levels and potentially contributing to hypothyroidism or thyroid dysfunction.
3. Adrenal Disorders: Insulin resistance and metabolic syndrome are associated with dysregulation of the hypothalamic-pituitary-adrenal (HPA) axis, leading to altered cortisol secretion and adrenal dysfunction. Chronic hyperinsulinemia may also stimulate adrenal steroidogenesis, contributing to conditions such as hypercortisolism or adrenal hyperplasia.
4. Pituitary Disorders: Insulin resistance and metabolic syndrome can disrupt the feedback mechanisms controlling pituitary hormone secretion, leading to alterations in growth hormone, prolactin, and other pituitary hormones. This dysregulation may contribute to disorders such as acromegaly, gigantism, or hypopituitarism.
5. Reproductive Hormone Disorders: Insulin resistance and hyperinsulinemia are associated with disturbances in reproductive hormone levels and function. In conditions like polycystic ovary syndrome (PCOS), insulin resistance contributes to hyperandrogenism, menstrual irregularities, and ovarian dysfunction, exacerbating infertility and other symptoms.
6. Parathyroid Disorders: Insulin resistance and metabolic syndrome may influence parathyroid hormone (PTH) secretion and calcium metabolism. Dysregulated insulin signaling pathways may affect calcium homeostasis, contributing to disturbances such as hyperparathyroidism or hypoparathyroidism.
7. Growth Disorders: Insulin resistance and hyperinsulinemia can impact growth hormone (GH) secretion and action, leading to alterations in growth hormone levels and signaling pathways. These disturbances may contribute to growth disorders such as acromegaly, gigantism, or growth hormone deficiency.

Overall, the dysregulation of insulin and metabolic processes seen in hyperinsulinemia, insulin resistance, and metabolic syndrome can disrupt endocrine function, exacerbate hormone imbalances, and contribute to the development and progression of various endocrine disorders. Management strategies targeting insulin sensitivity and metabolic health may help mitigate the risk and severity of these conditions.

 Adipose tissue releases hormones like leptin and adiponectin, affecting metabolism and insulin sensitivity. 

 Dysregulation of insulin production and glucose metabolism characterizes  diabetes, leading to hyperglycemia and insulin resistance. 

1. Gupta  L, Khandelwal D, Kalra S, Gupta P, Dutta D, Aggarwal S. Ketogenic diet  in endocrine disorders: Current perspectives. J Postgrad Med.  2017;63(4):242-251. doi:10.4103/jpgm.JPGM_16_17
2. Deru, L. et al. (2022) ‘Understanding the endocrine response to macronutrients in the context of a ketogenic diet’, The FASEB Journal, 36(S1). doi:10.1096/fasebj.2022.36.S1.R6073.
3. Renck  A, Sajoux I, Hallak J, Costa E. Metabolic and hormonal improvement  after ketogenic VLCD diet (VLCK): Case report. In: BioScientifica; 2019.  doi:10.1530/endoabs.63.P1155 ABSTRACT
4. Ec  C, Kac B, N E-S, Sjcmm N, Aj van der L. Eucaloric Very-Low-Carbohydrate  Ketogenic Diet in Acromegaly Treatment. The New England journal of  medicine. doi:10.1056/NEJMc1915808
5. Iacovides, S. et al. (2022) ‘Could the ketogenic diet induce a shift in thyroid function and  support a metabolic advantage in healthy participants? A pilot  randomized-controlled-crossover trial’, PLOS ONE, 17(6), p. e0269440. Available at: https://doi.org/10.1371/journal.pone.0269440.

  Cushing's syndrome is a rare disorder characterized by prolonged  exposure to high levels of cortisol, either due to excessive production  by the adrenal glands (adrenal Cushing's syndrome) or prolonged use of  corticosteroid medications (exogenous Cushing's syndrome). While  hyperinsulinemia, marked by elevated levels of insulin in the blood, is  not directly associated with Cushing's syndrome, it may play a role in  its development and progression. Insulin resistance, a hallmark of  hyperinsulinemia and metabolic syndrome, is associated with chronic  low-grade inflammation, which can contribute to adrenal dysfunction and  abnormal cortisol production. Additionally, hyperinsulinemia may  exacerbate symptoms such as weight gain, glucose intolerance, and  hypertension, which are common in individuals with Cushing's syndrome.  Furthermore, insulin resistance may impair adrenal responsiveness to  adrenocorticotropic hormone (ACTH), further contributing to cortisol  dysregulation in individuals with Cushing's syndrome. Therefore,  managing hyperinsulinemia through lifestyle modifications,  insulin-sensitizing medications, and appropriate medical interventions  may help alleviate symptoms and improve outcomes in individuals with  Cushing's syndrome. Additionally, individuals with Cushing's syndrome  should work closely with healthcare professionals to identify and  address the underlying cause of cortisol excess, optimize treatment, and  prevent complications associated with the condition. 

  Graves' disease is an autoimmune disorder characterized by the  overproduction of thyroid hormones, leading to hyperthyroidism. While  hyperinsulinemia, marked by elevated levels of insulin in the blood, is  not directly associated with Graves' disease, it may influence the  condition indirectly. Insulin resistance, a hallmark of hyperinsulinemia  and metabolic syndrome, can disrupt thyroid hormone production and  signaling pathways, potentially exacerbating thyroid dysfunction.  Additionally, hyperinsulinemia may contribute to autoimmune processes,  increasing the risk of conditions such as Graves' disease. Furthermore,  insulin resistance may worsen symptoms such as weight loss,  palpitations, and heat intolerance, commonly observed in individuals  with Graves' disease. Therefore, managing hyperinsulinemia through  lifestyle modifications, insulin-sensitizing medications, and  appropriate medical interventions may help alleviate symptoms and  improve outcomes in individuals with Graves' disease. Additionally,  individuals with Graves' disease should work closely with healthcare  professionals to optimize thyroid hormone levels, monitor symptoms, and  prevent complications associated with the condition. 

  "Although the diets were isocaloric and physical activity and resting  metabolic rate remained constant, the participants lost more mass after  the KD than after the HCLF diet. The observed significant changes in  triiodothyronine concentration suggest that unknown metabolic changes  occur in nutritional ketosis, changes that warrant further  investigation."  

 Type 1 diabetes is an autoimmune condition characterized by the  destruction of insulin-producing beta cells in the pancreas, leading to a  deficiency of insulin production. While hyperinsulinemia is not a  feature of type 1 diabetes, it can sometimes occur during the early  stages of the disease due to residual beta cell function or insulin  therapy. However, once beta cell destruction is complete, individuals  with type 1 diabetes typically have low or undetectable levels of  insulin in their blood. Therefore, while hyperinsulinemia is not  directly associated with type 1 diabetes, managing blood sugar levels  through exogenous insulin administration is essential for controlling  the condition and preventing complications. Additionally, lifestyle  factors such as diet, exercise, and stress management play important  roles in managing type 1 diabetes and optimizing overall health and  well-being.

1. Stamati, A. et al. (2023) ‘Efficacy and safety of carbohydrate restriction in patients  with type 1 diabetes: A systematic review and meta-analysis’, Diabetes, Obesity & Metabolism, 25(9), pp. 2770–2773. Available at: https://doi.org/10.1111/dom.15124.
2. Mahmood, B.S. (2023) ‘Impact of low carbohydrate diet on patients with type 1 Diabetes’, E3S Web of Conferences, 391, p. 01132. Available at: https://doi.org/10.1051/e3sconf/202339101132.
3. Schmidt  S, Christensen MB, Serifovski N, et al. Low versus High Carbohydrate  Diet in Type 1 Diabetes: A 12-week randomized open-label crossover  study. Diabetes Obes Metab. March 2019. doi:10.1111/dom.13725
4. Turton, J.L. et al. (2023) ‘Effects of a low-carbohydrate diet in adults with type 1  diabetes management: A single arm non-randomised clinical trial’, PLOS ONE, 18(7), p. e0288440. Available at: https://doi.org/10.1371/journal.pone.0288440.
5. Feinman  RD, Pogozelski WK, Astrup A, et al. Dietary carbohydrate restriction as  the first approach in diabetes management: critical review and evidence  base. Nutrition. 2015;31(1):1-13. doi:10.1016/j.nut.2014.06.011
6. Kleiner, A. et al. (2022) ‘Safety and Efficacy of Eucaloric Very Low-Carb Diet (EVLCD) in  Type 1 Diabetes: A One-Year Real-Life Retrospective Experience’, Nutrients, 14(15), p. 3208. Available at: https://doi.org/10.3390/nu14153208.
7. Krebs, J.D. et al. (2016) ‘A randomised trial of the feasibility of a low carbohydrate  diet vs standard carbohydrate counting in adults with type 1 diabetes  taking body weight into account’, Asia Pacific Journal of Clinical Nutrition, 25(1), pp. 78–84. Available at: https://doi.org/10.6133/apjcn.2016.25.1.11. ABSTRACT
8. Lehmann, V. et al. (2020) ‘Lower Daily Carbohydrate Intake Is Associated With Improved  Glycemic Control in Adults With Type 1 Diabetes Using a Hybrid  Closed-Loop System’, Diabetes Care [Preprint]. Available at: https://doi.org/10.2337/dc20-1560
9. Nielsen, J.V. et al. (2012) ‘Low carbohydrate diet in type 1 diabetes, long-term improvement and adherence: A clinical audit’, Diabetology & Metabolic Syndrome, 4(1), p. 23. Available at: https://doi.org/10.1186/1758-5996-4-23.
10. Dimosthenopoulos  C, Liatis S, Kourpas E, et al. The beneficial short-term effects of a  high-protein/low-carbohydrate diet on glycemic control assessed by  continuous glucose monitoring in patients with type 1 diabetes. Diabetes Obes Metab. Published online March 26, 2021. doi:10.1111/dom.14390 ABSTRACT
11. Paul, J. et al. (2022) ‘Association between a low carbohydrate diet, glycemic control,  and quality of life in Australian adults living with type 1 diabetes: a  pilot study’, Endocrine Practice: Official Journal of the American  College of Endocrinology and the American Association of Clinical  Endocrinologists, pp. S1530-891X(22)00578-X. Available at: https://doi.org/10.1016/j.eprac.2022.08.003.
12. Nielsen  JV, Jönsson E, Ivarsson A. A low carbohydrate diet in type 1 diabetes:  clinical experience–a brief report. Ups J Med Sci. 2005;110(3):267-273. doi:10.3109/2000-1967-074 
13. Herschede AM. Grit Pregnancies: How to Have a Healthy Pregnancy and Normal Blood Sugars with Type 1 Diabetes. Allison Herschede; 2021. ISBN-10 : 1737084309
14. Lake I. Nutritional ketosis is well-tolerated, even in type 1 diabetes: the ZeroFive100 Project; a proof-of-concept study. Current Opinion in Endocrinology, Diabetes and Obesity. 2021;28(5):453-462. doi:10.1097/MED.0000000000000666
15. Berger  B, Jenetzky E, Köblös D, et al. Seven-day fasting as a multimodal  complex intervention for adults with type 1 diabetes: Feasibility,  benefit and safety in a controlled pilot study. Nutrition. 2021;86:111169. doi:10.1016/j.nut.2021.111169 PDF
16. Ozoran, H. et al. (2023) ‘Type 1 diabetes and low carbohydrate diets—Defining the degree of nutritional ketosis’, Diabetic Medicine, 40(10), p. e15178. Available at: https://doi.org/10.1111/dme.15178.
17. Kristensen, K.B. et al. (2023) ‘Effects of a low-carbohydrate-high-protein pre-exercise meal in type 1 diabetes – a randomised, crossover trial’, The Journal of Clinical Endocrinology and Metabolism, p. dgad427. Available at: https://doi.org/10.1210/clinem/dgad427. ABSTRACT

1. Gardemann, C., Knowles, S. and Marquardt, T. (2023) ‘Managing type 1 diabetes mellitus with a ketogenic diet’, Endocrinology, Diabetes & Metabolism Case Reports, 2023(3). Available at: https://doi.org/10.1530/EDM-23-0008.
2. Eiswirth  M, Clark E, Diamond M. Low carbohydrate diet and improved glycaemic  control in a patient with type one diabetes. Endocrinol Diabetes Metab  Case Rep. 2018;2018. doi:10.1530/EDM-18-0002 
3. Buehler  LA, Noe D, Knapp S, Isaacs D, Pantalone KM. Ketogenic diets in the  management of type 1 diabetes: Safe or safety concern? CCJM. 2021;88(10):547-555. doi:10.3949/ccjm.88a.20121 (review & case report)
4. Thewjitcharoen  Y, Wanothayaroj E, Jaita H, et al. Prolonged Honeymoon Period in a Thai  Patient with Adult-Onset Type 1 Diabetes Mellitus. Case Reports in Endocrinology. 2021;2021:e3511281. doi:10.1155/2021/3511281
5. Tóth  C, Clemens Z. Type 1 diabetes mellitus successfully managed with the  paleolithic ketogenic diet. International Journal of Case Reports and  Images. 2014;5. doi:10.5348/ijcri-2014124-CR-10435 
6. Schönlaub  A, Höller A, Hofer S, Haberlandt E, Karall D, Scholl-Bürgi S. Glut1  Deficiency Syndrome and Diabetes Mellitus Type 1: Review of the  Literature and Presentation of a New Case. In: Neuropediatrics. Vol 52. Georg Thieme Verlag KG; 2021:FV1.32. doi:10.1055/s-0041-1739666
7. Oyibo,  S.O. (2022) ‘Partial Remission of Diabetes in a Young Adult While  Testing Positive for Several Islet Cell Autoantibodies: A Case Report,  Literature Review, and Patient Perspective’, Cureus, 14(6). Available at: https://doi.org/10.7759/cureus.25746.
8. Bouillet  B, Rouland A, Petit JM, Vergès B. A low-carbohydrate high-fat diet  initiated promptly after diagnosis provides clinical remission in three  patients with type 1 diabetes. Diabetes Metab. July 2019. doi:10.1016/j.diabet.2019.06.004 NO ABSTRACT

1. Lennerz BS, Barton A,  Bernstein RK, et al. Management of Type 1 Diabetes With a Very  Low-Carbohydrate Diet. Pediatrics. 2018;141(6). doi:10.1542/peds.2017-3349 
2. Neuman V, Plachy L, Pruhova S, et al. Low-Carbohydrate Diet among Children with Type 1 Diabetes: A Multi-Center Study. Nutrients. 2021;13(11):3903. doi:10.3390/nu13113903
3. Harray, A.J. et al. (2023) ‘Experiences and Attitudes of Parents Reducing Carbohydrate  Intake in the Management of Their Child’s Type 1 Diabetes: A Qualitative  Study’, Nutrients, 15(7), p. 1666. Available at: https://doi.org/10.3390/nu15071666.
4. Runge C, Lee JM. How Low Can You Go? Does Lower Carb Translate to Lower Glucose? Pediatrics. 2018;141(6). doi:10.1542/peds.2018-0957
5. Öz  NA, Arslanoglu I, Cangür S, Bolu S, Kocabay K. Low-carb Diet in  Hospitalized Late Pubertal Type 1 Diabetic Girls: A Short-Term CGM  Study. Indian J Endocrinol Metab. 2021;25(1):31-37. doi:10.4103/ijem.ijem_176_21
6. Rydin  AA, Spiegel G, Frohnert BI, et al. Medical Management of Children with  Type 1 Diabetes on Low Carbohydrate or Ketogenic Diets. Pediatric Diabetes. n/a(n/a). doi:https://doi.org/10.1111/pedi.13179
7. Tóth  C, Clemens Z. A child with type 1 diabetes mellitus (T1DM) successfully  treated with the Paleolithic ketogenic diet: A 19-month  insulin-freedom. IJCRI. 2015;6(12):752. doi:10.5348/ijcri-2015121-CR-10582
8. de  Souza Bosco Paiva C, Lima MHM. Introducing a very low carbohydrate diet  for a child with type 1 diabetes. Br J Nurs. 2019;28(15):1015-1019.  doi:10.12968/bjon.2019.28.15.1015 ABSTRACT

 Type 2 diabetes is a metabolic disorder characterized by high blood  sugar levels resulting from insulin resistance and relative insulin  deficiency. Hyperinsulinemia, marked by elevated levels of insulin in  the blood, is a hallmark feature of insulin resistance and plays a  central role in the development and progression of type 2 diabetes.  Insulin resistance occurs when cells in the body become less responsive  to the effects of insulin, leading to impaired glucose uptake and  utilization. Over time, the pancreas may compensate by producing more  insulin to overcome this resistance, resulting in hyperinsulinemia.  Chronic hyperinsulinemia, along with other factors such as obesity,  sedentary lifestyle, and genetic predisposition, contributes to the  progression of insulin resistance and eventual beta-cell dysfunction,  leading to the development of type 2 diabetes. Therefore, managing  hyperinsulinemia through lifestyle modifications, including a healthy  diet, regular exercise, weight management, and possibly  insulin-sensitizing medications, is crucial for preventing and managing  type 2 diabetes and its associated complications. 

 Type 2 diabetes (T2D) exerts a widespread impact on the human body, affecting multiple systems and increasing the risk of various complications. In the cardiovascular system, T2D contributes to hypertension, dyslipidemia, atherosclerosis, and increased risk of heart disease and stroke. It also impairs microvascular circulation, leading to diabetic retinopathy, nephropathy, and neuropathy. T2D adversely affects the respiratory system, increasing the risk of obstructive sleep apnea and respiratory infections. Metabolically, T2D disrupts glucose metabolism, leading to hyperglycemia, insulin resistance, and metabolic syndrome, which further exacerbate systemic inflammation and oxidative stress. T2D is closely associated with non-alcoholic fatty liver disease, contributing to liver dysfunction and cirrhosis. Musculoskeletal complications include osteoporosis, osteoarthritis, and increased fracture risk. Additionally, T2D affects mental health, increasing the risk of depression, anxiety, and cognitive decline. Overall, T2D significantly impacts quality of life, functional abilities, and life expectancy. Management of T2D involves lifestyle modifications, blood sugar monitoring, medication, and regular medical care to prevent or delay complications and improve overall health outcomes. 

Elevated insulin causing insulin resistance is clearly demonstrated  in people with type 2 diabetes. As you probably know, a common method of  treating type 2 diabetes is to give the patient insulin injections. On  the surface, this seems like the logical thing to do. “Everybody knows  diabetics need insulin,” right?

However, because insulin itself causes insulin resistance, by administering insulin injections, the patient is steadily making themselves increasingly insulin-resistant. This is evident in the fact that type 2 diabetics usually find themselves needing more and more insulin injections over time.

 59 Year old doctor from Germany takes health into her own hands and reverses her type 2 diabetes. She helps people understand the power of diet and lifestyle and the limits of mainstream medical care. 

 "a well-planned LCHF meal plan can be considered micronutrient replete. This is an important finding for health professionals and consumers as it dispels the myth that these diets are suboptimal in their micronutrient supply. As with any diet, for optimal nutrient achievement, meals need to be well formulated "

"After 30 months with T2 diabetes all the patients would be expected to have lost some renal function so in that context the average significant improvements were astonishing Not one of our patients has ever had to come off the lower carb diet because of this  "  Dr D Unwin

From The Nutrition  Network 

There have now been a number of reviews on this topic. A recent (07/2021) narrative review paper from Wheatley et al  https://www.frontiersin.org/articles/10.3389/fnut.2021.687658/full is an excellent overview of the literature, the remaining areas of  controversy, and practical recommendations. A recent review of  meta-analyses and clinical trials from Dyńka et al https://www.mdpi.com/2072-6643/15/3/500 contains useful summary tables of trials. In addition, this paper from Brown et al  https://onlinelibrary.wiley.com/doi/10.1111/jhn.12938 focuses on options for remission (08/2021).

1. Li  S, Ding L, Xiao X. Comparing the Efficacy and Safety of  Low-Carbohydrate Diets with Low-Fat Diets for Type 2 Diabetes Mellitus  Patients: A Systematic Review and Meta-Analysis of Randomized Clinical  Trials. International Journal of Endocrinology. 2021;2021:e8521756. doi:10.1155/2021/8521756
2. Yuan  X, Wang J, Yang S, et al. Effect of the ketogenic diet on glycemic  control, insulin resistance, and lipid metabolism in patients with T2DM:  a systematic review and meta-analysis. Nutrition & Diabetes. 2020;10(1):1-8. doi:10.1038/s41387-020-00142-z
3. Meng  Y, Bai H, Wang S, Li Z, Wang Q, Chen L. Efficacy of low carbohydrate  diet for type 2 diabetes mellitus management: A systematic review and  meta-analysis of randomized controlled trials. Diabetes Research and  Clinical Practice. 2017;131:124-131. doi:10.1016/j.diabres.2017.07.006 ABSTRACT
4. Alarim  RA, Alasmre FA, Alotaibi HA, Alshehri MA, Hussain SA. Effects of the  Ketogenic Diet on Glycemic Control in Diabetic Patients: Meta-Analysis  of Clinical Trials. Cureus. 12(10). doi:10.7759/cureus.10796
5. Turton  J, Brinkworth GD, Field R, Parker H, Rooney K. An evidence‐based  approach to developing low‐carbohydrate diets for type 2 diabetes  management: a systematic review of interventions and methods. Diabetes,  Obesity and Metabolism. doi:10.1111/dom.13837
6. Snorgaard  O, Poulsen GM, Andersen HK, Astrup A. Systematic review and  meta-analysis of dietary carbohydrate restriction in patients with type 2  diabetes. BMJ Open Diabetes Res Care. 2017;5(1):e000354. doi:10.1136/bmjdrc-2016-000354
7. Ajala  O, English P, Pinkney J. Systematic review and meta-analysis of  different dietary approaches to the management of type 2 diabetes. Am J  Clin Nutr. 2013;97(3):505-516. doi:10.3945/ajcn.112.042457
8. Goldenberg  JZ, Day A, Brinkworth GD, et al. Efficacy and safety of low and very  low carbohydrate diets for type 2 diabetes remission: systematic review  and meta-analysis of published and unpublished randomized trial data. BMJ. 2021;372:m4743. doi:10.1136/bmj.m4743
9. Churuangsuk, C. et al. (2021) ‘Diets for weight management in adults with type 2 diabetes: an  umbrella review of published meta-analyses and systematic review of  trials of diets for diabetes remission’, Diabetologia. doi:10.1007/s00125-021-05577-2
10. Apekey, T.A. et al. (2022) ‘Comparison of the Effectiveness of Low Carbohydrate Versus Low  Fat Diets, in Type 2 Diabetes: Systematic Review and Meta-Analysis of  Randomized Controlled Trials’, Nutrients, 14(20), p. 4391. Available at: https://doi.org/10.3390/nu14204391.
11. Kelly  T, Unwin D, Finucane F. Low-Carbohydrate Diets in the Management of  Obesity and Type 2 Diabetes: A Review from Clinicians Using the Approach  in Practice. International Journal of Environmental Research and Public  Health. 2020;17(7):2557. doi:10.3390/ijerph17072557
12. Hallberg  SJ, Gershuni VM, Hazbun TL, Athinarayanan SJ. Reversing Type 2  Diabetes: A Narrative Review of the Evidence. Nutrients. 2019;11(4):766.  doi:10.3390/nu11040766
13. Feinman  RD, Pogozelski WK, Astrup A, et al. Dietary carbohydrate restriction as  the first approach in diabetes management: Critical review and evidence  base. Nutrition. 2015;31(1):1-13. doi:10.1016/j.nut.2014.06.011
14. Taylor R, Ramachandran A, Yancy WS, Forouhi NG. Nutritional basis of type 2 diabetes remission. BMJ. 2021;374:n1449. doi:10.1136/bmj.n1449

1. Tay J, Thompson CH,  Luscombe-Marsh ND, et al. Effects of an energy-restricted  low-carbohydrate, high unsaturated fat/low saturated fat diet versus a  high-carbohydrate, low-fat diet in type 2 diabetes: A 2-year randomized  clinical trial. Diabetes Obes Metab. 2018;20(4):858-871. doi:10.1111/dom.13164
2. Saslow  LR, Daubenmier JJ, Moskowitz JT, et al. Twelve-month outcomes of a  randomized trial of a moderate-carbohydrate versus very low-carbohydrate  diet in overweight adults with type 2 diabetes mellitus or prediabetes.  Nutr Diabetes. 2017;7(12):304. doi:10.1038/s41387-017-0006-9
3. Goday  A, Bellido D, Sajoux I, et al. Short-term safety, tolerability and  efficacy of a very low-calorie-ketogenic diet interventional weight loss  program versus hypocaloric diet in patients with type 2 diabetes  mellitus. Nutr Diabetes. 2016;6(9):e230. doi:10.1038/nutd.2016.36
4. Tay  J, Luscombe-Marsh ND, Thompson CH, et al. Comparison of low- and  high-carbohydrate diets for type 2 diabetes management: a randomized  trial. Am J Clin Nutr. 2015;102(4):780-790. doi:10.3945/ajcn.115.112581
5. Tay  J, Luscombe-Marsh ND, Thompson CH, et al. A very low-carbohydrate,  low-saturated fat diet for type 2 diabetes management: a randomized  trial. Diabetes Care. 2014;37(11):2909-2918. doi:10.2337/dc14-0845
6. Chen  C-Y, Huang W-S, Chen H-C, et al. Effect of a 90 g/day low-carbohydrate  diet on glycaemic control, small, dense low-density lipoprotein and  carotid intima-media thickness in type 2 diabetic patients: An 18-month  randomised controlled trial. PLOS ONE. 2020;15(10):e0240158. doi:10.1371/journal.pone.0240158
7. Durrer  C, McKelvey S, Singer J, et al. A randomized controlled trial of  pharmacist-led therapeutic carbohydrate and energy restriction in type 2  diabetes. Nat Commun. 2021;12(1):5367. doi:10.1038/s41467-021-25667-4
8. Thomsen  MN, Skytte MJ, Astrup A, et al. The clinical effects of a  carbohydrate-reduced high-protein diet on glycaemic variability in  metformin-treated patients with type 2 diabetes mellitus: A randomised  controlled study. Clinical Nutrition ESPEN. Published online August 1,  2020. doi:10.1016/j.clnesp.2020.07.002 ABSTRACT
9. Han, Y. et al. (2021) ‘A Low-Carbohydrate Diet Realizes Medication Withdrawal: A Possible Opportunity for Effective Glycemic Control’, Frontiers in Endocrinology, 12. doi:10.3389/fendo.2021.779636.
10. Yamada  Y, Uchida J, Izumi H, et al. A Non-calorie-restricted Low-carbohydrate  Diet is Effective as an Alternative Therapy for Patients with Type 2  Diabetes. Internal Medicine. 2014;53(1):13-19. doi:10.2169/internalmedicine.53.0861
11. Athinarayanan  SJ, Adams RN, Hallberg SJ, et al. Long-Term Effects of a Novel  Continuous Remote Care Intervention Including Nutritional Ketosis for  the Management of Type 2 Diabetes: A 2-Year Non-randomized Clinical  Trial. Front Endocrinol. 2019;10. doi:10.3389/fendo.2019.00348 
12. McKenzie  A, Athinarayanan S, Adams R, Volek J, Phinney S, Hallberg S. SUN-LB113 A  Continuous Remote Care Intervention Utilizing Carbohydrate Restriction  Including Nutritional Ketosis Improves Markers of Metabolic Risk and  Reduces Diabetes Medication Use in Patients With Type 2 Diabetes Over  3.5 Years. J Endocr Soc. 2020;4(Supplement_1). doi:10.1210/jendso/bvaa046.2302 (5 Year Data https://doi.org/10.2337/db22-832-P )
13. Guldbrand  H, Lindström T, Dizdar B, et al. Randomization to a low-carbohydrate  diet advice improves health related quality of life compared with a  low-fat diet at similar weight-loss in Type 2 diabetes mellitus.  Diabetes Res Clin Pract. 2014;106(2):221-227. doi:10.1016/j.diabres.2014.08.032
14. Unwin, D. et al. (2020) ‘Insights from a general practice service evaluation supporting a  lower carbohydrate diet in patients with type 2 diabetes mellitus and  prediabetes: a secondary analysis of routine clinic data including  HbA1c, weight and prescribing over 6 years’, BMJ Nutrition, Prevention & Health, 3(2), pp. 285–294. Available at: https://doi.org/10.1136/bmjnph-2020-000072.
15. Unwin, D. et al. (2023) ‘What predicts drug-free type 2 diabetes remission? Insights  from an 8-year general practice service evaluation of a lower  carbohydrate diet with weight loss’, BMJ Nutrition, Prevention & Health, p. e000544. Available at: https://doi.org/10.1136/bmjnph-2022-000544.
16. Nielsen  JV, Joensson EA. Low-carbohydrate diet in type 2 diabetes: stable  improvement of bodyweight and glycemic control during 44 months  follow-up. Nutrition & Metabolism. 2008;5(1):14. doi:10.1186/1743-7075-5-14
17. Moriconi  E, Camajani E, Fabbri A, Lenzi A, Caprio M. Very-Low-Calorie Ketogenic  Diet as a Safe and Valuable Tool for Long-Term Glycemic Management in  Patients with Obesity and Type 2 Diabetes. Nutrients. 2021;13(3):758. doi:10.3390/nu13030758
18. Romano  L, Marchetti M, Gualtieri P, et al. Effects of a Personalized VLCKD on  Body Composition and Resting Energy Expenditure in the Reversal of  Diabetes to Prevent Complications. Nutrients. 2019;11(7):1526. doi:10.3390/nu11071526
19. Taylor  PJ, Thompson CH, Luscombe-Marsh ND, Wycherley TP, Wittert G, Brinkworth  GD. Efficacy of Real-Time Continuous Glucose Monitoring to Improve  Effects of a Prescriptive Lifestyle Intervention in Type 2 Diabetes: A  Pilot Study. Diabetes Ther. 2019;10(2):509-522. doi:10.1007/s13300-019-0572-z
20. Ahmed  SR, Bellamkonda S, Zilbermint M, Wang J, Kalyani RR. Effects of the low  carbohydrate, high fat diet on glycemic control and body weight in  patients with type 2 diabetes: experience from a community-based cohort.  BMJ Open Diabetes Res Care. 2020;8(1). doi:10.1136/bmjdrc-2019-000980
21. Govers  E, Otten A, Schuiling B, Bouwman W, Visscher T. Effectiveness of the 6 ×  6 Dieet® in Obese DMT2 Patients Effectiveness of a Very Low  Carbohydrate Ketogenic Diet Compared to a Low Carbohydrate and  Energy-Restricted Diet in Overweight/Obese Type 2 Diabetes Patients.  September 2019. doi:10.16966/2380-548X.158
22. Karkee  A, Singh S, Shrestha PK, Shakya NS, Shrestha S, Niroula S. Effect of  Dietary Intervention Using Low-Carbohydrate Diet to Manage Newly  Diagnosed Type 2 Diabetes Mellitus in TUTH Hospital, Nepal. Nepalese Medical Journal. 2021;4(1):419-423. doi:10.3126/nmj.v4i1.34710
23. Wolver  S, Fadel K, Fieger E, et al. Clinical Use of a Real-World Low  Carbohydrate Diet Resulting in Reduction of Insulin Dose, Hemoglobin  A1c, and Weight. Front Nutr. 2021;8:690855. doi:10.3389/fnut.2021.690855
24. Laza-Cagigas  R, Chan S, Sumner D, Rampal T. Effects and feasibility of a  prehabilitation programme incorporating a low-carbohydrate, high-fat  dietary approach in patients with type 2 diabetes: A retrospective  study. Diabetes Metab Syndr. 2020;14(3):257-263. doi:10.1016/j.dsx.2020.03.010
25. Soto-Mota  A, Norwitz NG, Evans R, Clarke K, Barber TM. Exogenous ketosis in  patients with type 2 diabetes: Safety, tolerability and effect on  glycaemic control. Endocrinology, Diabetes & Metabolism. n/a(n/a):e00264. doi:https://doi.org/10.1002/edm2.264

1. Cummings, P.J. et al. (2023) ‘Rapid remission of chronic, progressive conditions and reducing  polypharmacy by utilizing lifestyle therapy to target insulinemic  lifestyle components’, AJPM Focus, p. 100118. Available at: https://doi.org/10.1016/j.focus.2023.100118.
2. Iwasaki K. Low carbohydrate diet rescued severe type 2 diabetes patient from insulin injection, a case report. Journal of Family Medicine and Primary Care. 2021;10(1):550. doi:10.4103/jfmpc.jfmpc_1798_20 
3. Nie  L, Zhai Q, Wei Y, Wang T, Li P. Ketogenic Diets Potentially Reverse  Type 2 Diabetes Via Continuous Remote Care Intervention: A Case Study in  Central China. Current Developments in Nutrition. 2021;5(Supplement_2):437-437. doi:10.1093/cdn/nzab038_049
4. Jones  EC, Jardet CL. Functional Improvement in -Islet Cells and Hepatocytes  with Decreasing Deuterium from Low Carbohydrate Intake in a Type-II  Diabetic. Medical Research Archives. 2021;9(6). doi:10.18103/mra.v9i6.2475
5. Gavidia  K, Kalayjian T. Treating Diabetes Utilizing a Low Carbohydrate  Ketogenic Diet and Intermittent Fasting Without Significant Weight Loss:  A Case Report. Front Nutr. 2021;8. doi:10.3389/fnut.2021.687081

1. Wang X, Li Q, Liu Y,  Jiang H, Chen W. Intermittent fasting versus continuous  energy-restricted diet for patients with type 2 diabetes mellitus and  metabolic syndrome for glycemic control: A systematic review and  meta-analysis of randomized controlled trials. Diabetes Res Clin Pract. Published online August 12, 2021:109003. doi:10.1016/j.diabres.2021.109003 ABSTRACT
2. Borgundvaag  E, Mak J, Kramer CK. Metabolic impact of intermittent fasting in  patients with type 2 diabetes mellitus: a systematic review and  meta-analysis of interventional studies. J Clin Endocrinol Metab. Published online December 15, 2020. doi:10.1210/clinem/dgaa926
3. Obermayer, A. et al. (2022) ‘Efficacy and Safety of Intermittent Fasting in People With  Insulin-Treated Type 2 Diabetes (INTERFAST-2)-A Randomized Controlled  Trial’, Diabetes Care, p. dc221622. Available at: https://doi.org/10.2337/dc22-1622.
4. Albosta  M, Bakke J. Intermittent fasting: is there a role in the treatment of  diabetes? A review of the literature and guide for primary care  physicians. Clinical Diabetes and Endocrinology. 2021;7(1):3. doi:10.1186/s40842-020-00116-1
5. Furmli  S, Elmasry R, Ramos M, Fung J. Therapeutic use of intermittent fasting  for people with type 2 diabetes as an alternative to insulin. Case  Reports. 2018;2018:bcr-2017-221854. doi:10.1136/bcr-2017-221854  
6. Li  C, Sadraie B, Steckhan N, et al. Effects of A One-week Fasting Therapy  in Patients with Type-2 Diabetes Mellitus and Metabolic Syndrome – A  Randomized Controlled Explorative Study. Exp Clin Endocrinol Diabetes.  2017;125(9):618-624. doi:10.1055/s-0043-101700 ABSTRACT
7. Gabel  K, Kroeger CM, Trepanowski JF, et al. Differential Effects of  Alternate-Day Fasting Versus Daily Calorie Restriction on Insulin  Resistance. Obesity. 0(0). doi:10.1002/oby.22564
8. DiNicolantonio  JJ, McCarty M. Autophagy-induced degradation of Notch1, achieved  through intermittent fasting, may promote beta cell neogenesis:  implications for reversal of type 2 diabetes. Open Heart.  2019;6(1):e001028. doi:10.1136/openhrt-2019-001028
9. Zubrzycki  A, Cierpka-Kmiec K, Kmiec Z, Wronska A. The role of low-calorie diets  and intermittent fasting in the treatment of obesity and type-2  diabetes. J Physiol Pharmacol. 2018;69(5). doi:10.26402/jpp.2018.5.02 

•  Double diabetes, also known as hybrid diabetes, refers to a condition in  which individuals exhibit characteristics of both type 1 and type 2  diabetes. This condition typically occurs in individuals who have type 1  diabetes (characterized by autoimmune destruction of pancreatic beta  cells leading to insulin deficiency) but also display features of  insulin resistance commonly seen in type 2 diabetes. In double diabetes,  insulin resistance may develop due to factors such as obesity,  sedentary lifestyle, genetic predisposition, or hormonal imbalances. The  presence of both insulin deficiency and insulin resistance can make  blood sugar management more challenging and may require a combination of  insulin therapy and medications that improve insulin sensitivity.  Management strategies for double diabetes typically include lifestyle  modifications such as diet and exercise, along with careful monitoring  of blood sugar levels and adjustment of insulin doses as needed.  Additionally, individuals with double diabetes should work closely with  healthcare professionals to optimize treatment, prevent complications,  and improve overall health outcomes. 

back in 1917 well before we knew that T1 and T2 were differenct, we used a low carb. diet to treat both .  Nothing has changed since about the best foods for both